跳至主要内容
临床试验/CTRI/2010/091/001368
CTRI/2010/091/001368已完成3 期

A randomized, open label, comparative, multicentric study to assess the efficacy and safety of Acrivastine capsules in comparison with Chlorpheniramine maleate tablets in patients suffering from allergic rhinitis

Cadila Healthcare Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex of 18 to 65 years of age
  • 2.Established diagnosis of allergic rhinitis
  • 3.Informed consent

排除标准

  • 1.Pregnancy & Lactation.
  • 2.Significant renal impairment.
  • 3.Narrow-angle glaucoma, GI or GUT obstruction.
  • 4.Patients with acute attack of bronchial asthma or those on corticosteroids.
  • 5.Nasal structural abnormalities
  • 6.Upper respiratory tract infection
  • 7.Hypersensitivity to study medications
  • 8.Patients with any other serious concurrent illness or malignancy
  • 9.Continuing history of alcohol and / or drug abuse
  • 10.Recent participation in another clinical trial

研究者

相似试验